Cases 21 - 30 of 41,108
BAYER INTELLECTUAL PROPERTY GMBH et al v. USV PRIVATE LIMITED
as 2:2022cv05485
Plaintiff:
BAYER INTELLECTUAL PROPERTY GMBH, BAYER PHARMA AG, BAYER AG and others
Defendant:
USV PRIVATE LIMITED
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
BAYER INTELLECTUAL PROPERTY GMBH et al v. USV PRIVATE LIMITED
as 3:2022cv05485
Plaintiff:
BAYER INTELLECTUAL PROPERTY GMBH, BAYER PHARMA AG, BAYER AG and others
Defendant:
USV PRIVATE LIMITED
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
Bayer Pharma AG, et al v. Mylan Pharmaceuticals Inc. et al
as 1:2022cv00063
Plaintiff:
Bayer Pharma AG,, Bayer AG, and Janssen Pharmaceuticals, Inc.
Defendant:
Mylan Pharmaceuticals Inc. and Mylan Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Gorski et al v. Janssen Research & Development LLC f/k/a Johnson and Johnson Pharmaceutical Research and Development, LLC et al
as 1:2022cv03481
Plaintiff:
Keiko Gorski and Florian Gorski
Defendant:
Janssen Research & Development LLC f/k/a Johnson and Johnson Pharmaceutical Research and Development, LLC, Janssen Ortho, LLC, Janssen Pharmaceuticals, Inc., f/k/a Janssen Pharmaceutica Inc. f/k/a Ortho-McNeil-Janssen Pharmaceuticals, Inc. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
McManus v. Janssen Research & Development LLC et al
as 2:2022cv01795
Plaintiff:
Edna McManus
Defendant:
Janssen Research & Development LLC, Bayer Healthcare Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Bayer Pharma AG et al v. Micro Labs Ltd. et al
as 1:2022cv00165
Counter Defendant:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Counter Claimant:
Micro Labs Ltd. and Micro Labs USA Inc.
Cause Of Action: 35 U.S.C. § 271
McKinley v. Johnson & Johnson et al
as 0:2021cv02665
Plaintiff:
Eric McKinley
Defendant:
Johnson & Johnson, Janssen Reseach & Development, LLC, Janssen Pharmaceuticals, Inc. and others
Cause Of Action: 28 U.S.C. § 1332 -pip-Diversity-Personal Injury, Product Liability
In Re: Xarelto (Rivaroxaban) ('310) Patent Litigation
as 1:2021md03017
In Re:
Xarelto (Rivaroxaban) ('310) Patent Litigation
Not Classified By Court:
Clerk of MDL Panel, Lupin Limited, Lupin Pharmaceuticals, Inc. and others
Counter Defendant:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
ScieGen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Bayer Pharma AG et al v. Mylan Pharmaceuticals Inc. et al
as 1:2021cv01742
Plaintiff:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals Inc.
Defendant:
Mylan Pharmaceuticals Inc. and Mylan Inc.
Cause Of Action: 35 U.S.C. § 271
McKinley v. Johnson & Johnson et al
as 4:2021cv06243
Plaintiff:
Eric McKinley
Defendant:
Johnson & Johnson, Janssen Research & Development, LLC, Janssen Pharmaceuticals, Inc. and others
Cause Of Action: 28 U.S.C. § 1441
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
